pocketful logo light
pocketful logo light
Concord Biotech Ltd logo

Concord Biotech Ltd

NSE: CONCORDBIO BSE: 543960

1051.20

(4.40%)

Mon, 01 Jun 2026, 07:02 pm

Concord Biotech Balance Sheet

Particulars201920202021202220232024
Interest expense on debt-11.67M-9.05M-61.35M-91.33M-31.26M-10.42M
Pretax equity in earnings
Equity in earnings1.50M-4.49M-36.38M19.59M33.71M-13.22M
Total assets9.41B11.83B13.15B15.16B17.03B20.38B
Total current assets5.39B6.07B6.33B7.28B8.96B11.35B
Cash and short term investments2.01B2.02B1.62B1.80B2.91B3.18B
Cash & equivalents24.09M51.44M6.67M34.99M208.17M9.04M
Short term investments1.98B1.97B1.62B1.77B2.70B3.17B
Total receivables, net1.97B2.13B2.60B3.13B3.69B5.43B
Accounts receivable - trade, net1.84B1.78B2.32B2.74B3.50B5.22B
Other receivables134.18M358.21M273.50M391.61M194.28M211.20M
Total inventory1.13B1.55B1.98B2.14B2.16B2.41B
Other current assets, total242.81M324.65M83.41M152.62M135.25M261.07M
Total non-current assets4.03B5.76B6.82B7.88B8.07B9.03B
Long term investments57.79M27.19M17.30M89.92M48.70M365.17M
Note receivable - long term42.98M19.47M6.92M9.01M18.19M17.55M
Investments in unconsolidated subsidiaries8.15M3.66M0020.59M7.37M
Other investments6.66M4.07M10.38M80.90M9.93M340.25M
Net property/plant/equipment3.96B5.64B6.70B7.73B7.94B8.52B
Gross property/plant/equipment4.65B6.57B8.08B9.60B10.33B11.40B
Deferred tax assets5.92M5.99M19.47M21.83M24.52M41.33M
Net intangible assets926.00K64.17M35.79M1.98M3.20M11.22M
Goodwill, net000000
Other intangibles, net926.00K64.17M35.79M1.98M3.20M11.22M
Other long term assets, total4.46M21.21M46.26M39.93M48.29M45.49M
Short term debt135.91M314.00M309.34M251.47M78.51M23.39M
Current portion of LT debt and capital leases135.91M263.01M265.96M251.47M78.51M19.58M
Short term debt excl. current portion of LT debt050.99M43.38M003.81M
Accounts payable712.33M463.97M831.06M938.00M944.35M1.13B
Income tax payable17.82M0089.99M54.94M101.27M
Long term debt384.63M578.83M315.59M63.99M18.87M6.30M
Long term debt excl. lease liabilities384.63M578.83M315.59M63.99M18.87M6.30M
Total equity7.70B9.99B11.03B12.90B15.27B18.13B
Shareholders' equity7.70B9.99B11.03B12.90B15.27B18.13B
Common equity, total7.70B9.99B11.03B12.90B15.27B18.13B
Other common equity292.18M292.18M292.18M292.18M292.18M292.18M
Total debt520.54M892.84M624.93M315.46M97.38M29.69M
Net debt-1.49B-1.13B-999.14M-1.49B-2.81B-3.15B
Change in accounts receivable-295.37M64.99M-527.69M-430.97M-786.60M-1.71B
Change in taxes payable
Change in accounts payable394.75M-225.13M365.32M98.81M-112.87M220.89M
Change in other assets/liabilities-122.71M-303.79M356.93M-18.42M44.05M96.54M
Sale of fixed assets & businesses1.70M0560.00K253.00K1.75M1.99M
Purchase/sale of investments, net425.12M88.68M395.22M-184.75M-718.69M-520.08M
Sale/maturity of investments5.24B6.82B5.61B6.25B7.66B8.33B
Purchase of investments-4.81B-6.74B-5.22B-6.43B-8.38B-8.85B
Other investing cash flow items, total000000
Issuance/retirement of debt, net388.08M383.21M-257.63M-250.00M-250.06M-58.49M
Issuance/retirement of long term debt388.08M332.22M-250.02M-250.00M-250.06M-58.49M
Issuance/retirement of short term debt050.99M-7.61M000
Issuance/retirement of other debt
Total cash dividends paid-805.45M-57.06M-705.21M-535.63M-714.53M-915.39M
Other financing cash flow items, total000000